Biomerica (BMRA) Cash from Operations (2010 - 2026)
Biomerica (BMRA) reported Cash from Operations of 1250000.0 for Q1 2026, down 19.62% on a YoY basis from 1555059.52 in Q1 2025, and down 26.14% sequentially from 991000.0 in Q4 2025.
Biomerica (BMRA) Cash from Operations (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Cash from Operations data on file, last reported at 1250000.0 in Q1 2026.
- For the quarter ending Q1 2026, Cash from Operations fell 19.62% year-over-year to 1250000.0; the trailing twelve-month figure through Feb 2026 stood at 3170000.0 (up 24.95% YoY), and the FY2025 full-year result was 3841000.0, up 28.35% from the prior year.
- Cash from Operations retreated to 1250000.0 in Q1 2026, from 991000.0 in the prior quarter.
- In the past five years, Cash from Operations ranged from a high of 2358296.0 in Q1 2022 to a low of 4256046.0 in Q2 2022.
- A 5-year average of 1122514.71 and a median of 1045000.0 in 2025 frame the typical range for Cash from Operations.
- Peak annual rise in Cash from Operations reached 272.92% in 2022, while the deepest fall reached 2174.21% in 2022.
- Tracing BMRA's Cash from Operations over 5 years: stood at 1213000.0 in 2022, then surged by 30.59% to 842000.0 in 2023, then grew by 6.06% to 791000.0 in 2024, then declined by 25.28% to 991000.0 in 2025, then slipped by 26.14% to 1250000.0 in 2026.
- Business Quant data shows BMRA's Cash from Operations at 1250000.0 in Q1 2026, 991000.0 in Q4 2025, and 268000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 1.32 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 581.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 2.57 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 348.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 43.80 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 525.60 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 220.10 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 290.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | -1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -1.25 Mn |
| Feb 28, 2026 | -1.25 Mn |
| Nov 30, 2025 | -991,000.00 |
| Nov 30, 2025 | -991,000.00 |
| Aug 31, 2025 | -268,000.00 |
| Aug 31, 2025 | -268,000.00 |
| May 31, 2025 | -661,000.00 |
| May 31, 2025 | -661,000.00 |
| Feb 28, 2025 | -1.05 Mn |
| Feb 28, 2025 | -1.05 Mn |
| Nov 30, 2024 | -791,000.00 |
| Nov 30, 2024 | -791,000.00 |
| Aug 31, 2024 | -1.34 Mn |
| Aug 31, 2024 | -1.34 Mn |
| May 31, 2024 | -1.04 Mn |
| May 31, 2024 | -1.04 Mn |
| Feb 29, 2024 | -1.80 Mn |
| Feb 29, 2024 | -1.80 Mn |
| Nov 30, 2023 | -842,000.00 |
| Nov 30, 2023 | -842,000.00 |